Research Studies
A Geriatric Assessment Intervention for Patients Aged 70 and Over Receiving Chemotherapy or Similar Agents for Advanced Cancer: Reducing Toxicity in Older Adults
National PI: Supriya Mohile, MD, MS (University of Rochester)
Protocol Summary on ClinicalTrials.gov Link
Study Status: Active, Not Recruiting
Funding: R01CA177592, U01CA233167, UG1CA189961
Clinical trial information: NCT02054741
Enrollment Period: May 2014 – December 2022
URCC13059 Protocol
URCC13059 Appendices
The Lancet Paper
The Lancet Supplement
Determining the Utility of an Assessment Tool for Older Adults with Cancer
National PI: William Dale, MD, PhD (City of Hope) [Original National PI: Arti Hurria, MD]
Protocol Summary on ClinicalTrials.gov Link
Study Status: Long-Term Follow-up
Funding: NIA K23 AG026749 (PI: A. Hurria); K24 AG055693 (PI: W. Dale); City of Hope’s Center for Cancer and Aging
Enrollment Period: November 2006 to October 201
Publications
Clinical and Biological Predictors of Chemotherapy Toxicity in Older Adults
National PI: Mina Sedrak, MD, MS (City of Hope) [Original National PI: Arti Hurria, MD]
Protocol Summary on ClinicalTrials.gov Link
Study Status: Long-Term Follow-up
Funding: NIA R01AG037037 (PI: A. Hurria); The Breast Cancer Research Foundation; City of Hope’s Center for Cancer and Aging
Enrollment Period: September 2011 to May 2017
Publications
Improving Communication in Older Cancer Patients and Their Caregivers (COACH)
National PI: Supriya Mohile, MD, MS (University of Rochester)
Protocol Summary on ClinicalTrials.gov Link
Study Status: Active, Not Recruiting
Funding: Patient-Centered Outcomes Research Institute (contract CD-12-11-4634; PI: S. Mohile); NIA R21/R33AG059206 (PI: S. Mohile, W. Dale, A. Hurria)
Enrollment Period: October 2014 to April 2017
Publications
Geriatric Assessment Intervention for Reducing Toxicity in Older Patients With Advanced Cancer
National PI: Supriya Mohile, MD, MS (University of Rochester)
Protocol Summary on ClinicalTrials.gov Link
Study Status: Active, Not Recruiting
Funding: NCI R01CA177592 (PI: S. Mohile)
Project Period: September 2013 to June 2020
Publications
Tolerability of the Combination of Lapatinib and Trastuzumab in Adults Aged 60 or older with HER2 Positive Metastatic Breast Cancer
National PI: Daneng Li, MD (City of Hope) [Original National PI: Arti Hurria, MD]
Protocol Summary on ClinicalTrials.gov Link
Study Status: Long-Term Follow-up
Funding: Novartis
Enrollment Period: April 2011 to May 2016
Publications
For more information regarding these research studies, complete the Contact Us inquiry form here.